Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery

International Journal of Pharmaceutics

Volumn 473, Issue 1-2, 2014, Pages 426-433

  Park, Ju Hwan ^a   Lee, Jae Young ^a   Termsarasab, Ubonvan ^a   Yoon, In Soo ^b   Ko, Seung Hak ^c   Shim, Jae Seong ^c,d   Cho, Hyun Jong ^e   Kim, Dae Duk ^a  

^a Seoul National University   (South Korea)

^b Mokpo National University   (South Korea)

^c Biogenics Inc   (South Korea)

^d Skin Tech Inc   (South Korea)

^e Kangwon National University   (South Korea)

Author keywords

Cancer diagnosis; Docetaxel; Embedding; Hyaluronic acid ceramide; PLGA nanoparticle; Tumor targeting

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; CERAMIDE; COUMARIN 6; COUMARIN DERIVATIVE; DOCETAXEL; FLUORESCENT DYE; HERMES ANTIGEN; HYALURONIC ACID CERAMIDE; HYALURONIC ACID DERIVATIVE; NANOMATERIAL; NANOPARTICLE; POLYGLACTIN; UNCLASSIFIED DRUG; HYALURONIC ACID; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

3T3 CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER CELL LINE; CELLS; CONTROLLED STUDY; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG TARGETING; FIBROBLAST; INFRARED SPECTROSCOPY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOLID STATE; SUSTAINED DRUG RELEASE; TUMOR XENOGRAFT; X RAY DIFFRACTION; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HUMAN; METABOLISM; NEOPLASM; POWDER DIFFRACTION; TUMOR CELL LINE;

ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CELL LINE, TUMOR; CELL SURVIVAL; CERAMIDES; DRUG DELIVERY SYSTEMS; HUMANS; HYALURONIC ACID; LACTIC ACID; MICE; NANOSTRUCTURES; NEOPLASMS; NIH 3T3 CELLS; POLYGLYCOLIC ACID; POWDER DIFFRACTION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 84905503958     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.07.038     Document Type: Article

References (37)

1. S. Acharya, and S.K. Sahoo PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect Adv. Drug Deliv. Rev. 63 2011 170 183
2. A. Bunschoten, T. Buckle, J. Kuil, G.D. Luker, K.E. Luker, O.E. Nieweg, and F.W. van Leeuwen Targeted non-covalent self-assembled nanoparticles based on human serum albumin Biomaterials 33 2012 867 875
3. Z. Cheng, A. Al Zaki, J.Z. Hui, V.R. Muzykantov, and A. Tsourkas Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities Science 338 2012 903 910
4. H. Cho, and G.S. Kwon Polymeric micelles for neoadjuvant cancer therapy and tumor-primed optical imaging ACS Nano 5 2011 8721 8729
5. H.J. Cho, H.Y. Yoon, H. Koo, S.H. Ko, J.S. Shim, J.H. Lee, K. Kim, I.C. Kwon, and D.D. Kim Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel Biomaterials 32 2011 7181 7190
6. H.J. Cho, H.Y. Yoon, H. Koo, S.H. Ko, J.S. Shim, J.H. Cho, J.H. Park, K. Kim, I.C. Kwon, and D.D. Kim Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis J. Control. Release 162 2012 111 118
7. H.J. Cho, I.S. Yoon, H.Y. Yoon, H. Koo, Y.J. Jin, S.H. Ko, J.S. Shim, K. Kim, I.C. Kwon, and D.D. Kim Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin Biomaterials 33 2012 1190 1200
8. K.Y. Choi, H.Y. Yoon, J.H. Kim, S.M. Bae, R.W. Park, Y.M. Kang, I.S. Kim, I.C. Kwon, K. Choi, S.Y. Jeong, K. Kim, and J.H. Park Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy ACS Nano 5 2011 8591 8599
9. F. Danhier, O. Feron, and V. Préat To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J. Control. Release 148 2010 135 146
10. F. Danhier, E. Ansorena, J.M. Silva, R. Coco, A. Le Breton, and V. Préat PLGA-based nanoparticles: an overview of biomedical applications J. Control. Release 161 2012 505 522
11. S. Ganesh, A.K. Iyer, D.V. Morrissey, and M.M. Amiji Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors Biomaterials 34 2013 3489 3502
12. N. Graf, D.R. Bielenberg, N. Kolishetti, C. Muus, J. Banyard, O.C. Farokhzad, and S.J. Lippard α(V)β(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug ACS Nano 6 2012 4530 4539
13. S. Hiscox, B. Baruha, C. Smith, R. Bellerby, L. Goddard, N. Jordan, Z. Poghosyan, R.I. Nicholson, P. Barrett-Lee, and J. Gee Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan BMC Cancer 12 2012 458 472
14. Y.J. Jin, U. Termsarasab, S.H. Ko, J.S. Shim, S. Chong, S.J. Chung, C.K. Shim, H.J. Cho, and D.D. Kim Hyaluronic acid derivative-based self-assembled nanoparticles for the treatment of melanoma Pharm. Res. 29 2012 3443 3454
15. N. Kamaly, Z. Xiao, P.M. Valencia, A.F. Radovic-Moreno, and O.C. Farokhzad Targeted polymeric therapeutic nanoparticles: design development and clinical translation Chem. Soc. Rev. 41 2012 2971 3010
16. C.G. Keum, Y.W. Noh, J.S. Baek, J.H. Lim, C.J. Hwang, Y.G. Na, S.C. Shin, and C.W. Cho Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid Int. J. Nanomed. 6 2011 2225 2234
17. H. Koo, S. Lee, J.H. Na, S.H. Kim, S.K. Hahn, K. Choi, I.C. Kwon, S.Y. Jeong, and K. Kim Bioorthogonal copper-free click chemistry in vivo for tumor-targeted delivery of nanoparticles Angew. Chem. Int. Ed. Engl. 51 2012 11836 11840
18. T. Lammers, F. Kiessling, W.E. Hennink, and G. Storm Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress J. Control. Release 161 2012 175 187
19. S.J. Lee, H. Koo, H. Jeong, M.S. Huh, Y. Choi, S.Y. Jeong, Y. Byun, K. Choi, K. Kim, and I.C. Kwon Comparative study of photosensitizer loaded and conjugated glycol chitosan nanoparticles for cancer therapy J. Control. Release 152 2011 21 29
20. X. Ma, Y. Zhao, and X.J. Liang Theranostic nanoparticles engineered for clinic and pharmaceutics Acc. Chem. Res. 44 2011 1114 1122
21. H. Maeda, H. Nakamura, and J. Fang The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo Adv. Drug Deliv. Rev. 65 2013 71 79
22. S. Manoocheheri, B. Darvishi, G. Kamalinia, M. Amini, M. Fallah, S.N. Ostad, F. Atyabi, and R. Dinarvand Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel Daru 21 2013 58 67
23. S. Marrache, and S. Dhar Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics Proc. Natl. Acad. Sci. U. S. A. 109 16 2012 288 16293
24. S. Misra, P. Heldin, V.C. Hascall, N.K. Karamanos, S.S. Skandalis, R.R. Markwald, and S. Ghatak Hyaluronan-CD44 interactions as potential targets for cancer therapy FEBS J. 278 2011 1429 1443
25. L. Mo, L. Hou, D. Guo, X. Xiao, P. Mao, and X. Yang Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells Int. J. Pharm. 436 2012 815 824
26. C.F. Mu, P. Balakrishnan, F.D. Cui, Y.M. Yin, Y.B. Lee, H.G. Choi, C.S. Yong, S.J. Chung, C.K. Shim, and D.D. Kim The effects of mixed MPEG-PLA/Pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel Biomaterials 31 2010 2371 2379
27. M.C. Park, J.S. Baek, C.A. Lee, and C.W. Cho Effect of chitosan on physicochemical properties of exenatide-loaded PLGA nanoparticles J. Pharm. Invest. 43 2013 489 497
28. C. Surace, S. Arpicco, A. Dufaÿ-Wojcicki, V. Marsaud, C. Bouclier, D. Clay, L. Cattel, J.M. Renoir, and E. Fattal Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells Mol. Pharm. 6 2009 1062 1073
29. S.I. Thamake, S.L. Raut, Z. Gryczynski, A.P. Ranjan, and J.K. Vishwanatha Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer Biomaterials 33 2012 7164 7173
30. U. Termsarasab, H.J. Cho, D.H. Kim, S. Chong, S.J. Chung, C.K. Shim, H.T. Moon, and D.D. Kim Chitosan oligosaccharide-arachidic acid-based nanoparticles for anti-cancer drug delivery Int. J. Pharm. 441 2013 373 380
31. U. Termsarasab, H.J. Cho, H.T. Moon, J.H. Park, I.S. Yoon, and D.D. Kim Self-assembled magnetic resonance imaging nanoprobes based on arachidyl chitosan for cancer diagnosis Colloids Surf. B Biointerfaces 109 2013 280 286
32. J.W. Yoo, and S. Mitragotri Polymer particles that switch shape in response to a stimulus Proc. Natl. Acad. Sci. U. S. A. 107 11 2010 205 11210
33. G. Yoon, J.W. Park, and I.S. Yoon Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): recent advances in drug delivery J. Pharm. Invest. 43 2013 353 362
34. H.Y. Yoon, H. Koo, K.Y. Choi, I.C. Kwon, K. Choi, J.H. Park, and K. Kim Photo-crosslinked hyaluronic acid nanoparticles with improved stability for in vivo tumor-targeted drug delivery Biomaterials 34 2013 5273 5280
35. X. Zeng, W. Tao, L. Mei, L. Huang, C. Tan, and S.S. Feng Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer Biomaterials 34 2013 6058 6067
36. R. Zhang, K. Luo, J. Yang, M. Sima, Y. Sun, M.M. Janát-Amsbury, and J. Kopeček Synthesis and evaluation of a backbone biodegradable multiblock HPMA copolymer nanocarrier for the systemic delivery of paclitaxel J. Control. Release 166 2013 66 74
37. J. Zhou, T.R. Patel, M. Fu, J.P. Bertram, and W.M. Saltzman Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors Biomaterials 33 2012 583 591